Pharmaceutical Manufacturing is Witnessing Major Transformation as New Demands for Sterility Assurance Reshape Healthcare

 

For an industry where precision and quality control are paramount, pharmaceutical manufacturing is witnessing an evolutionary leap in contamination control practices. Propelled by changes in regulatory environments, such as the EU’s Annex 1 update and ICH Q9 focusing on quality risk management, the sector is shifting from isolated, data-point-centric strategies towards a more holistic approach. 

This transformation emphasizes the integration of various operational elements – from facility design to process controls – under a single, strategic umbrella of sterility assurance. As this shift towards comprehensive, AI and machine learning assisted processes reshapes the pharmaceutical manufacturing industry. Exploring this on “Exceeding Your Benchmark,” a podcast by Benchmark Products, is Fred Ayers. The Advisor for Sterility Assurance for Global Quality Systems at Eli Lilly is an industry expert, and shared some of his insights as he’s been at the forefront of this change.

 

Recent Episodes

Advancements in artificial intelligence are transforming healthcare, and remote cardiac monitoring is at the forefront of this change. With cardiovascular disease impacting nearly 50% of the population at some point in their lives, early detection and efficient diagnosis are crucial. Enter AI-powered cardiac monitors that provide near real-time data, reduce diagnostic errors, and improve…

In a groundbreaking move, CGFNS International has launched the first-ever global specialty credential for rehabilitation nurses, the Certified Global Nurse Rehabilitation (CGNR) exam. This credential marks a pivotal step toward addressing the critical need for globally standardized competencies in rehabilitation care. The development of this certification was a multi-year effort, uniting rehabilitation specialists from diverse…

Healthcare facilities face significant challenges in procuring and managing medical imaging equipment. These high-cost, high-stakes purchases, such as MRI and CT scanners, can directly impact patient care and financial sustainability. With declining reimbursements and increasingly complex technologies, the importance of expert guidance in making these decisions has never been greater. In fact, in 2022,…